The cell models used so far for tau studies are either malignant [neuroblastoma, PC12; (48)] or transgenic (49, 50) cell lines suffering from the consequences of genomic modifications in the epigenetic state different from normal cells with endogenous tau protein. The gene discussed is MAPT; the disease is neuroblastoma.